LFB S.A.'s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic Leukemia
8/26/2010 8:14:08 AM
More...
|
GTC Biotherapeutics (GTCB) Announces Conversion of LFB S.A.'s Preferred Stock into Common Shares and Provides a Portfolio Update
1/8/2010 10:20:41 AM
More...
|
The French Biopharmaceutical Group LFB S.A. Has Announced the First-in-Man Injections of Its First Two Therapeutic Monoclonal Antibodies and the Filing of BLAs for a New-Generation Immunoglobulin and a Fibrinogen
2/10/2009 10:04:33 AM
More...
|